[Updated 1:45 p.m. ET] Executive compensation held relatively steady in 2011 among privately-held life sciences companies, while their peers in the technology sector continued to see salary increases, according to the annual CompStudy survey produced by executive search firm J. Robert Scott and law firm WilmerHale in collaboration with Noam Wasserman, associate professor of business administration … Continue reading “Survey: Tech Executives Saw More Pay in 2011, Life Sciences Inched Up”
Category: Boston
Ray Ozzie’s Next Big Thing: Cocomo
Since when is naming your startup and posting a job ad news? When your name is Ray Ozzie, that’s when. The former Microsoft chief software architect and Lotus veteran has surfaced after a year of working behind the scenes. Ozzie reached out to the Boston Globe‘s Scott Kirsner with a teaser about his new project: … Continue reading “Ray Ozzie’s Next Big Thing: Cocomo”
Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs
Another six months have gone by, so it must be time for another deal for Forma Therapeutics. Sure enough, Watertown, MA-based Forma is announcing today it has struck a partnership to discover new cancer drugs with Germany-based Boehringer Ingelheim. The deal provides $65 million to Forma in a combination of upfront cash and four years’ … Continue reading “Forma Cuts $65M Deal With Boehringer Ingelheim to Discover Cancer Drugs”
FirstFuel Software Selected for DoD Energy Efficiency Initiative
Lexington, MA-based FirstFuel Software is among a crop of experimental energy projects picked to help the Department of Defense curb its energy output across military installations, the company announced yesterday. The startup was one of 27 teams selected as part of the DoD’s Installation Energy Test Bed initiative, a program designed to help emerging energy technologies … Continue reading “FirstFuel Software Selected for DoD Energy Efficiency Initiative”
GITR Lands $1,250,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ee131e85-0505-4426-87f6-048c5c5db3de&Preview=1 Date 1/5/2012 Company Name GITR Mailing Address 55 Cambridge Parkway Cambridge, MA 02142 Company Description The company is developing novel approaches to immunomodulatory responses to cancer. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,250,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture … Continue reading “GITR Lands $1,250,000 New Round”
Soteira Receives $347,362 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=92dc48ef-5814-4b72-a46d-456e172c0eff&Preview=1 Date 1/5/2012 Company Name Soteira Mailing Address 14 Tech Circle Natick, MA 01760 Company Description Soteira, Inc. is developing a system for treatment of vertebral compression fractures in patients with osteoporosis, cancer or traumatic injuries. Soteira’s design provides a superior biomechanical structure and better control of cement flow than other solutions. … Continue reading “Soteira Receives $347,362 New Financing Round”
Quanterix Garners New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d87755ba-6890-4e05-b8e0-a1945c269cf8&Preview=1 Date 1/5/2012 Company Name Quanterix Mailing Address One Kendall Square Building 1400 Cambridge, MA 02139 Company Description At Quanterix, our principal focus is to improve human health by providing physicians, drug developers, and researchers with the ability to detect and analyze important biomolecules within complex biological samples at the level of … Continue reading “Quanterix Garners New Funding Round”
ImmuneXcite Secures $2,418,788 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6a3e0123-a943-4794-979a-ac243e3a532e&Preview=1 Date 1/5/2012 Company Name ImmuneXcite Mailing Address 64 Grove Street Watertown, MA 02472 Company Description ImmuneXcite has developed a proprietary platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets. Website http://www.immunexcite.com Transaction Type Venture Equity Transaction Amount $2,418,788 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “ImmuneXcite Secures $2,418,788 New Funding”
Moontoast Receives $6,000,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=614ea515-8d88-4248-903f-2ffa9375c525&Preview=1 Date 1/5/2012 Company Name Moontoast Mailing Address 300 Brickstone Square Andover, MA 01810 Company Description Moontoast is the leading Distributed Social Commerce Platform for Retailers, Publishers, Musicians and Celebrities. The Moontoast platform enables brands to engage, share, analyze and drive revenue from your fans and consumers directly within any site fans … Continue reading “Moontoast Receives $6,000,000 New Round”
Founder Dialogues VII
E-Ink co-founder Russ Wilcox will be the featured speaker at this installment of Founder Dialogues, put on by Founder Collective and moderated by the firm’s managing partner Eric Paley. Event details and registration are here.
VC Fundraising Scorecard: General Catalyst, Excel, OpenView, & More
[Updated 1/5/12] The first week of the new year is a good time to take stock of where venture capital firms are in their fundraising progress. No question that unless you’re a top-tier firm—and even then, in some cases—raising a sizeable new fund has been very challenging. Back in August, I ran a summary of … Continue reading “VC Fundraising Scorecard: General Catalyst, Excel, OpenView, & More”
Report: Sermo Founders Off to New Company
Founders of Sermo, the Cambridge, MA-based provider of an online community for physicians, are off to a new health-focused Web startup. The news was first reported today at online publication Pharmalot, which noted Sermo CEO Daniel Palestrant’s departure. Sermo founder and chief medical officer Adam Sharp is also a founder of the new startup, Par8o, according to … Continue reading “Report: Sermo Founders Off to New Company”
Inspiration Bio Founders and Execs Inspired by New Boston Headquarters
When New York hedge fund manager John Taylor co-founded Inspiration Biopharmaceuticals in 2004, his main goal was to help his son, who suffers from the blood-clotting disorder hemophilia. So he and co-founder Scott Martin—a Texan who also has a child with hemophilia—set up a virtual biotech company and began pursuing new treatments for the disease. … Continue reading “Inspiration Bio Founders and Execs Inspired by New Boston Headquarters”
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment
Isis Pharmaceuticals has found a new partner in Biogen Idec that’s betting a large amount of money on a new therapy for a rare spinal disorder in newborns. Weston, MA-based Biogen Idec (NASDAQ: [[ticker:BIIB]]) said today that it has agreed to work with Carlsbad, CA-based Isis Pharmaceuticals (NASDAQ: [[ticker:ISIS]]) on an experimental antisense drug for … Continue reading “Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment”
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug
Alnylam Pharmaceuticals has been saying for a while that it needs hard data from clinical trials to prove its skeptics wrong, and today it’s coming out with an early hint of effectiveness with its RNA interference-based treatment for lowering cholesterol. Cambridge, MA-based Alnylam (NASDAQ: [[ticker:ALNY]]) is announcing today that it has gotten some encouraging results … Continue reading “Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug”
Loosen the Rules Stifling IPOs by Venture-Backed Startups
[Editor’s Note: We asked selected Xconomists a series of questions designed to zero in on the big issues of the year, including “What would you be willing to throw a punch over?”] What would I be willing to throw a punch over? Solving the small-cap IPO bottleneck … to unleash the job creating potential of … Continue reading “Loosen the Rules Stifling IPOs by Venture-Backed Startups”
The Boston Tech Year in Review: Endeca, RSA, and More
A lot has happened in the technology world in the past year. So let’s take a minute to reflect on the defining moments of 2011 and where we stand now, as a local tech community with increasingly global impact. This is by no means comprehensive, or even a summary of the most important stories of … Continue reading “The Boston Tech Year in Review: Endeca, RSA, and More”
GrabCAD Obtains $4,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8d2dae2-43d4-44fc-89f8-03e417a57de5&Preview=1 Date 1/4/2012 Company Name GrabCAD Mailing Address One Cambridge Center 6th Floor Cambridge, MA 02142 Company Description GrabCAD is a services marketplace that connects manufacturing and product development companies with CAD engineers around the world. Website http://www.grabcad.com Transaction Type Venture Equity Transaction Amount $4,000,000 Transaction Round Series A Proceeds Purposes Adobe … Continue reading “GrabCAD Obtains $4,000,000 Series A Funding Round”
Combinent BioMedical Systems Secures $750,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=294ce247-bde8-4b21-9584-36b5b18d7a3b&Preview=1 Date 1/4/2012 Company Name Combinent BioMedical Systems Mailing Address 420 Bedford Street Lexington, MA 02420 Company Description Combinent BioMedical Systems, Inc. is an emerging specialty pharmaceutical company that is developing novel drug combinations and formulations of existing pharmaceutical products using its proprietary transvaginal drug delivery system (TVDS). Website http://www.combinentbms.com Transaction Type … Continue reading “Combinent BioMedical Systems Secures $750,000 New Funding Round”
KnowledgeVision Systems Obtains $2,000,000 Series A Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=90326601-8b7f-4bcf-b00d-8961d64436fd&Preview=1 Date 1/4/2012 Company Name KnowledgeVision Systems Mailing Address 676 Elm St. Concord, MA 01742 Company Description Finally, an enterprise-level tool for synchronizing video, PowerPoint, footnotes, handout attachments, and images together into engaging, informative experiences available at any time! Website http://www.knowledgevision.com Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Series A … Continue reading “KnowledgeVision Systems Obtains $2,000,000 Series A Funding Round”
Xconomy is Looking for a Digital Media Intern to Join Our Cambridge Offices
Hey intern hopefuls, have you been on the hunt for a sweet media gig for the new semester? You’re in luck. Xconomy is looking for a rockstar intern to help out with a mix of editorial, social media, and event-related projects we’re initiating in the new year. On top of gaining professional Web and news … Continue reading “Xconomy is Looking for a Digital Media Intern to Join Our Cambridge Offices”
Diabetes Drugs Could Cure Cancer
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] Drugs for type 2 diabetes have the potential to become effective therapies for certain types of cancers. Tumor cells have increased energy needs, and starving them of … Continue reading “Diabetes Drugs Could Cure Cancer”
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls
[Updated] Aveo Pharmaceuticals is starting the New Year with news that it has passed the most important clinical trial in company history, although it appears to have barely eked out the victory, which disappointed investors. Cambridge, MA-based Aveo (NASDAQ: [[ticker:AVEO]]) said today that its lead experimental drug reached its goal in a pivotal clinical trial … Continue reading “Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls”
VelQuest Bought by Accelrys for $35M
‘Tis the season for end-of-year acquisitions to be announced, now that everyone’s back at work. Hopkinton, MA-based VelQuest, a maker of pharmaceutical and medical device-related software, has been acquired by San Diego-based Accelrys (NASDAQ: [[ticker:ACCL]]), the scientific R&D software firm, for $35 million in cash. VelQuest started in 1999 and is led by CEO and … Continue reading “VelQuest Bought by Accelrys for $35M”
Merck Leads $10M Funding of HIV Diagnostics Firm Daktari
Cambridge, MA-based Daktari Diagnostics announced in late December that it has raised $10 million in financing from a syndicate of private and venture firms. The funding round was led by Merck Global Health Innovation Fund, a unit of Whitehouse Station, NJ-based Merck (NYSE: [[ticker:MRK]]). Also participating in this funding round were Daktari’s existing investors, Norwich … Continue reading “Merck Leads $10M Funding of HIV Diagnostics Firm Daktari”
Counting Coups: Better, Fewer Deals in 2011 for Venture-Backed Cos.
2011 was a year of bigger deals and fewer exits for venture-backed companies, according to data being released today by Dow Jones VentureSource. VentureSource says that venture-backed companies netted $53.2 billion through a total of 522 deals of all kinds in 2011—mergers, buyouts, and IPOs. That was a 14 percent decline in the number of … Continue reading “Counting Coups: Better, Fewer Deals in 2011 for Venture-Backed Cos.”
Healthcare That Works
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] Reinventing the absolutely dysfunctional healthcare delivery system in the U.S. It is a daunting idea, as it requires major changes in 100 years worth of doctor and … Continue reading “Healthcare That Works”
Smart Destinations Out to Make Big City Tourist Travel Family-Friendly
Boston has a pretty well-known cluster of tech companies—young and old—that are focused on aspects of travel like booking flights and hotels. Kayak, TripAdvisor, and ITA Software (now part of Google), just to name a few, fit that mold. But there’s another area player that’s helping customers to experience a city once they get there, … Continue reading “Smart Destinations Out to Make Big City Tourist Travel Family-Friendly”
All-Electric Transportation
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] All-electric commercial boats, ships, railway engines, and aircraft. The hyper-convergence of energy generation, battery storage, electric vehicle systems development, and electric charging infrastructure has first focused commercially … Continue reading “All-Electric Transportation”
Technology That Finally Helps Learning
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?”] That technology can actually play a significant positive role in education. The false promises go back at least 100 years—to extravagant claims by Thomas Edison. Certainly “computers … Continue reading “Technology That Finally Helps Learning”
Permeon Garners $2,500,600 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69842c7b-1ce0-40f1-8bbf-b7865c857083&Preview=1 Date 12/30/2011 Company Name Permeon Mailing Address One Memorial Drive 7th Floor Cambridge, MA 02142 Company Description Permeon brings together visionary scientists and proven leadership to drive innovation in therapeutic drug development. Website http://www.permeonbio.com Transaction Type Debt, Venture Equity Transaction Amount $2,500,600 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “Permeon Garners $2,500,600 New Funding Round”
Alternative Online Payments: The Dream That Refuses to Die
[Editor’s note: As a New Year’s exercise, we asked a select group of Xconomists to answer this question: “What’s the craziest idea out there that just might succeed?” ] After nearly twenty years of failed attempts, I’m still a believer in the potential transformative power of the “crazy idea” of alternative Internet payment systems, particularly … Continue reading “Alternative Online Payments: The Dream That Refuses to Die”
Alexion Pharmaceuticals Acquires Enobia Pharma for $1,080,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8f877e7-cbd0-4f56-bf35-3c8c854e8dbf&Preview=1 Date 12/29/2011 Company Name Enobia Pharma Mailing Address 55 Cambridge Parkway Cambridge, MA 02142 Company Description Enobia Pharma is a developer of enzyme replacement therapies for the treatment of serious bone diseases. Website http://www.enobia.com Transaction Type M&A Transaction Amount $1,080,000,000 Transaction Round Proceeds Purposes M&A Terms Alexion has agreed to pay … Continue reading “Alexion Pharmaceuticals Acquires Enobia Pharma for $1,080,000,000”
Call Genie Acquires VoodooVox for $2,800,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51360e37-b359-47e1-a99e-8d348d75bad1&Preview=1 Date 12/29/2011 Company Name VoodooVox Mailing Address 1321 Mass MoCA Way North Adams, MA 01247 Company Description VoodooVox is creating a new advertising medium in In-Call Advertising. Through the VoodooVox In-Call Network, VoodooVox brings together advertisers, telecom firms, and callers to create profit out of interactive phone experiences. Website http://www.voodoovox.com Transaction … Continue reading “Call Genie Acquires VoodooVox for $2,800,000”
Healthy Transgenic Foods
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Transgenic foods that are programmed and cultivated not so much to lower costs at the risk of ruining health and the environment, but the opposite—like a tomato that produces lots of Omega3 … Continue reading “Healthy Transgenic Foods”
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011
‘Tis the season to reflect on the past year and take a look at some of Xconomy Boston’s top stories. As usual, these aren’t necessarily the highest-traffic stories (though in some cases they are). They are stories that exemplify what we are trying to deliver to our readers every day—narratives about the people, companies, and … Continue reading “Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011”
Cure for Diabetes
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] If I can only pick one, I’d patent a functional cure for diabetes—whether it’s an artificial pancreas, a treatment to spare beta cells, or a means to prevent insulin resistance. However it … Continue reading “Cure for Diabetes”
Onco Tree DTS Lands $2,400,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=37fd3856-58c7-4fef-a297-22f8d0b16042&Preview=1 Date 12/28/2011 Company Name Onco Tree DTS Mailing Address 16 Lantern Road Framingham, MA 01702 Company Description You have arrived at the pre-opening of OncoTree Discovery & Translation Services, Inc., a new life sciences company bringing vascular informatics to oncology research, drug discovery and translational development. Website http://www.oncotreedts.com Transaction Type Venture … Continue reading “Onco Tree DTS Lands $2,400,000 New Funding”
Medrobotics Lands $11,700,000 Series C Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=097f66c4-654c-4af4-a90f-8c5113e5533e&Preview=1 Date 12/28/2011 Company Name Medrobotics Mailing Address 475 Paramount Drive Raynham, MA 02767 Company Description Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University and the University of Pittsburgh as well as additional robust development of its own intellectual property portfolio. The Company has an operational facility in … Continue reading “Medrobotics Lands $11,700,000 Series C Funding”
Daktari Diagnostics Obtains $4,999,987 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b5ead850-e61d-4887-ad7c-ea0bf30b6b54&Preview=1 Date 12/28/2011 Company Name Daktari Diagnostics Mailing Address 85 Bolton St Cambridge, MA 02140 Company Description Daktari Diagnostics, Inc., is a new diagnostics company focused exclusively on the most pressing challenges in global health. The company develops simple, accurate, and affordable products that deliver critical diagnostic information to clinicians and patients … Continue reading “Daktari Diagnostics Obtains $4,999,987 New Round”
Bacteria to Do Our Bidding
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Broad claims covering delivery of therapeutics using engineered bacteria. Synthetic biology tools emerging in just the last few years have made this possible. The trick, of course, is precise control. If I … Continue reading “Bacteria to Do Our Bidding”
Beyond the iPad to the hPad
[Editor’s note: We asked a group of Xconomists to answer the following question: “If you could patent one thing, what would it be?”] Two patents: a. A low-cost holographic pad: an “hPad,” which would sit on your desk and project three-dimensional fixed and moving images. It would include a touchscreen-like functionality. This would not only … Continue reading “Beyond the iPad to the hPad”
OnChip Power Garners $1,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4967417d-1eb5-4e45-91cf-398d4839c4ee&Preview=1 Date 12/27/2011 Company Name OnChip Power Mailing Address One Cambridge Center 6th Floor Cambridge, MA 02142 Company Description The company develops power electronics technology. Website http://www.onchippower.com Transaction Type Venture Equity Transaction Amount $1,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing-amended. M&A Terms Venture Investor Undisclosed
Owncloud Secures $820,797 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a57e8a1e-6038-4b34-8af4-630a3f851e2e&Preview=1 Date 12/26/2011 Company Name Owncloud Mailing Address 12 Foster Road Lexington, MA 02421 Company Description ownCloud gives you universal access to your files through a web interface or WebDAV. It also provides a platform to easily view & sync your contacts, calendars and bookmarks across all your devices and enables basic … Continue reading “Owncloud Secures $820,797 New Financing Round”
TripAdvisor Post-IPO: Five Things We Learned From CEO Stephen Kaufer
Merry Christmas, Boston. You asked for it, and you got it. A big, publicly traded consumer tech company to put us on the map alongside the Silicon Valley bad boys and uppity New Yorkers. I present to you: TripAdvisor (NASDAQ: [[ticker:TRIP]]). Sure, we already have Zipcar (NASDAQ: [[ticker:ZIP]]), Carbonite (NASDAQ: [[ticker:CARB]]), iRobot (NASDAQ: [[ticker:IRBT]]), and … Continue reading “TripAdvisor Post-IPO: Five Things We Learned From CEO Stephen Kaufer”
WGBH Xconomy Report: TripAdvisor, Amazon, & More
Our partnership with the folks at WGBH continues as we join forces again this week to bring you the Xconomy Report. In this week’s innovation news, TripAdvisor goes public and independent, breaking ties with Expedia. Seattle-based Amazon.com makes plans for a Boston-area office, which will open in Cambridge early next year. And much more, including … Continue reading “WGBH Xconomy Report: TripAdvisor, Amazon, & More”
Beyond the Tablet Wars: Apple, Amazon, and the Cloud
Much has been written on the battle between Apple and Amazon. Certainly Steve Jobs’ passing has made us all reflect, and perhaps on a much deeper level than before, on the man and the empire he created. In many ways, the companies are more alike than they are different. What makes them both remarkable players … Continue reading “Beyond the Tablet Wars: Apple, Amazon, and the Cloud”
Momenta, Baxter Team Up on Biosimilars
Illinois-based Baxter International (NYSE: [[ticker:BAX]]) is tapping into Cambridge, MA-based Momenta Pharmaceuticals’ abilities as a generic drugmaker in a new collaboration deal focused on developing so-called biosimilars, or knockoffs of biologic drugs. Momenta (NASDAQ: [[ticker:MNTA]]) will receive $33 million upfront in the deal, according to an announcement yesterday, and could receive another $419 million in potential milestones … Continue reading “Momenta, Baxter Team Up on Biosimilars”
Acceleron Adds $30M From Partner Celgene and Existing Investors
Cambridge, MA-based Acceleron Pharma announced today that it has raised $30 million in a private financing round. One of the participants in this round was Summit, NJ-based Celgene (NASDAQ: [[ticker:CELG]]), which has a partnership with Acceleron to develop two drugs to treat anemia. The two companies expanded their partnership most recently in August, when Celgene … Continue reading “Acceleron Adds $30M From Partner Celgene and Existing Investors”
Boston’s Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers
According to the National Science Foundation, eighth grade girls are half as likely to be interested in science, technology, engineering and math (STEM) careers as boys—a dramatic change from second grade, where the numbers are roughly equal. This trend continues through high school, college and into the workplace, as even women with advanced science degrees … Continue reading “Boston’s Women in Bio Aims to Fuel STEM Curiosity In Middle Schoolers”